AAAAAA

   
Results: 1-10 |
Results: 10
PARKINSONS-DISEASE SELECTIVELY IMPAIRS PREATTENTIVE AUDITORY PROCESSING - AN MEG STUDY
Authors: PEKKONEN E AHVENINEN J VIRTANEN J TERAVAINEN H
Citation: E. Pekkonen et al., PARKINSONS-DISEASE SELECTIVELY IMPAIRS PREATTENTIVE AUDITORY PROCESSING - AN MEG STUDY, NeuroReport, 9(13), 1998, pp. 2949-2952
SIMULTANEOUS MAO-B AND COMT INHIBITION IN L-DOPA-TREATED PATIENTS WITH PARKINSONS-DISEASE
Authors: LYYTINEN J KAAKKOLA S AHTILA S TUOMAINEN P TERAVAINEN H
Citation: J. Lyytinen et al., SIMULTANEOUS MAO-B AND COMT INHIBITION IN L-DOPA-TREATED PATIENTS WITH PARKINSONS-DISEASE, Movement disorders, 12(4), 1997, pp. 497-505
DETERMINATION OF M-O-METHYLATED AND P-O-METHYLATED PRODUCTS OF LEVODOPA AND COMT ACTIVITY IN PARKINSONS-DISEASE
Authors: KAAKKOLA S NISSINEN E TERAVAINEN H
Citation: S. Kaakkola et al., DETERMINATION OF M-O-METHYLATED AND P-O-METHYLATED PRODUCTS OF LEVODOPA AND COMT ACTIVITY IN PARKINSONS-DISEASE, Journal of neurochemistry, 69, 1997, pp. 174-174
COMPARISON OF IMMEDIATE-RELEASE AND CONTROLLED-RELEASE CARBIDOPA LEVODOPA IN PARKINSONS-DISEASE - A MULTICENTER 5-YEAR STUDY/
Authors: BLOCK G LISS C REINES S IRR J NIBBELINK D AARLI J AGUILAR M AHRENS S BAKHEIT A BAUMEL B BERTONI J CAPILDEO R CASTROCALDAS A DEZA L DONALDSON I FRANCK G FUSILLO J GAUTHIER S GERSHANIK O GRANERUS AK HAUSER RA HENNESSEY K HUTTON JT JOFFE R KOLLER W LAST B LEWITT P MAMOLI B MANYAM B MARK M NAKANO K NAUSIEDA P OTERO E PAULSON G PINTER M REICH S RODNITZKY R SAGE J SAMPAIO C SMITH B TERAVAINEN H TETRUD J TOLOSA E ULM G VALESCO F
Citation: G. Block et al., COMPARISON OF IMMEDIATE-RELEASE AND CONTROLLED-RELEASE CARBIDOPA LEVODOPA IN PARKINSONS-DISEASE - A MULTICENTER 5-YEAR STUDY/, European neurology, 37(1), 1997, pp. 23-27
CEREBROSPINAL-FLUID ACTIVITY OF TISSUE-PLASMINOGEN ACTIVATOR IN PATIENTS WITH NEUROLOGICAL DISEASES
Authors: AKENAMI FOT SIREN V KOSKINIEMI M SIIMES MA TERAVAINEN H VAHERI A
Citation: Fot. Akenami et al., CEREBROSPINAL-FLUID ACTIVITY OF TISSUE-PLASMINOGEN ACTIVATOR IN PATIENTS WITH NEUROLOGICAL DISEASES, Journal of Clinical Pathology, 49(7), 1996, pp. 577-580
COMT INHIBITION WITH ENTACAPONE IN PARKINSON PATIENTS TREATED EITHER WITH SINEMET OR SINEMET CR
Authors: TERAVAINEN H KAAKKOLA S GORDIN A AHTILA S RITA H
Citation: H. Teravainen et al., COMT INHIBITION WITH ENTACAPONE IN PARKINSON PATIENTS TREATED EITHER WITH SINEMET OR SINEMET CR, Neurology, 44(4), 1994, pp. 10000259-10000259
EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON CLINICAL DISABILITY AND LEVODOPA METABOLISM IN PARKINSONIAN-PATIENTS
Authors: KAAKKOLA S TERAVAINEN H AHTILA S RITA H GORDIN A
Citation: S. Kaakkola et al., EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON CLINICAL DISABILITY AND LEVODOPA METABOLISM IN PARKINSONIAN-PATIENTS, Neurology, 44(1), 1994, pp. 77-80
PRECENTRAL AND POSTCENTRAL CORTICAL SOMATOSENSORY-EVOKED POTENTIALS IN HEMIPARKINSONISM
Authors: HUTTUNEN J TERAVAINEN H
Citation: J. Huttunen et H. Teravainen, PRECENTRAL AND POSTCENTRAL CORTICAL SOMATOSENSORY-EVOKED POTENTIALS IN HEMIPARKINSONISM, Movement disorders, 8(4), 1993, pp. 430-436
EFFECTS OF ENTACAPONE, A COMT INHIBITOR, ON L-DOPA METABOLISM IN PARKINSONS-DISEASE (PD)
Authors: KAAKKOLA S TERAVAINEN H AHTILA S GORDIN A
Citation: S. Kaakkola et al., EFFECTS OF ENTACAPONE, A COMT INHIBITOR, ON L-DOPA METABOLISM IN PARKINSONS-DISEASE (PD), Neurology, 43(4), 1993, pp. 197-197
SUPPRESSION OF MAGNETIC MU-RHYTHM DURING PARKINSONIAN TREMOR
Authors: MAKELA JP HARI R KARHU J SALMELIN R TERAVAINEN H
Citation: Jp. Makela et al., SUPPRESSION OF MAGNETIC MU-RHYTHM DURING PARKINSONIAN TREMOR, Brain research, 617(2), 1993, pp. 189-193
Risultati: 1-10 |